Stay up-to-date by following us on and

For more information, contact-us.

The biotechnology market accounted for 7% of the pharmaceutical industry’s market in 2006. Today, it provides the best growth potential to the biopharmaceutical industry while modifying the landscape and issues of this sector. Whether it deals with biologic or chemical compounds, involving new mechanisms of action or being presented as an incremental evolution, biopharmaceutical innovation is carrying new hopes for diseases’ prevention and treatment. Since 2009, the Innovation Prize aims to identify and promote these discoveries in order to boost their development by supporting them along the road to success.

With more than 500 000 different medical devices, the Medtech sectorshares a common goal between its innovations: increasing the length and improving the quality of life of patients. This booming sector has been valued at $ 100 billion worldwide with a provisional annual growth of 5% until 2020. The Innovation Prize, by assessing these promising and innovative technologies, offers the opportunity and the chance to their project leaders getting a concrete feedback from expert jury members from institutional groups and private companies.

The digital revolution through both the dematerialization and the rise of numerical reshapes the healthcare sector’s landscape. With digital, this sector is experimenting deep modifications impacting relationship between laboratories, practitioners, patients and organization itself, allowing the healthcare industry to become a true partner throughout information and training. For this 10th edition, Universal Biotech chose to reward this category by including it to the Innovation Prize together with biotech and medtech projects.